UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the quarterly period ended September 30, 2002 OR |
||
| [ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the transition period from ____________ to __________
Commission file number 0-26820
| Washington (State or other jurisdiction of incorporation or organization) |
93-0962605 (I.R.S. Employer Identification No.) |
411 First Avenue South, Suite 600
Seattle, WA 98104-2860
(206) 701- 2000
(Address of principal executive offices)
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
As of November 12, 2002, 51,702,953 shares of the Companys Common Stock, par value $0.01 per share, were outstanding.
CRAY INC. AND SUBSIDIARIES
TABLE OF CONTENTS
| Page No. | ||||||
| PART I | FINANCIAL INFORMATION | |||||
| Item 1. | Unaudited Condensed Consolidated Financial Statements: | |||||
| Balance Sheets as of December 31, 2001 And September 30, 2002 | 3 | |||||
| Statements of Operations for the Three And Nine Months Ended September 30, 2001 and 2002 | 4 | |||||
| Statements of Shareholders Equity for the Nine Months Ended September 30, 2002 | 5 | |||||
| Statements of Cash Flows for the Nine Months Ended September 30, 2001 and 2002 | 6 | |||||
| Notes to Financial Statements | 7 | |||||
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations | 10 | ||||
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 21 | ||||
| Item 4. | Controls and Procedures | 21 | ||||
| PART II | OTHER INFORMATION | |||||
| Item 1. | Legal Proceedings | 22 | ||||
| Item 2. | Changes in Securities and Use of Proceeds | 22 | ||||
| Item 5. | Other Information | 23 | ||||
| Item 6. | Exhibits and Reports on Form 8-K | 23 |
2
CRAY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
ASSETS
| December 31, | September 30, | ||||||||||
| 2001 | 2002 | ||||||||||
Current assets: |
|||||||||||
Cash and cash equivalents |
$ | 12,377 | $ | 27,350 | |||||||
Restricted cash |
353 | 38 | |||||||||
Accounts receivable, net of allowance of $936 in
2001 and 2002 |
24,764 | 25,285 | |||||||||
Inventory, net |
18,950 | 18,221 | |||||||||
Prepaid expenses and other assets |
3,954 | 6,889 | |||||||||
Total current assets |
60,398 | 77,783 | |||||||||
Property and equipment, net |
27,668 | 26,024 | |||||||||
Service spares, net |
12,267 | 9,365 | |||||||||
Goodwill, net |
22,680 | 22,680 | |||||||||
Long-term receivable |
550 | 550 | |||||||||
Deferred tax asset |
743 | 998 | |||||||||
Other assets |
2,781 | 3,297 | |||||||||
TOTAL |
$ | 127,087 | $ | 140,697 | |||||||
| LIABILITIES AND SHAREHOLDERS EQUITY | |||||||||||
Current liabilities: |
|||||||||||
Accounts payable |
$ | 11,295 | $ | 6,600 | |||||||
Accrued payroll and related expenses |
12,063 | 15,588 | |||||||||
Accrued loss on purchase commitment |
4,602 | ||||||||||
Other accrued liabilities |
5,850 | 6,581 | |||||||||
Deferred revenue |
22,762 | 19,807 | |||||||||
Current portion of warranty reserves |
6,574 | 4,262 | |||||||||
Current portion of obligations under capital leases |
347 | 286 | |||||||||
Current portion of term loan |
2,143 | 2,143 | |||||||||
Current portion of notes payable |
486 | 265 | |||||||||
Total current liabilities |
66,122 | 55,532 | |||||||||
Warranty reserves |
8,479 | 3,262 | |||||||||
Obligations under capital leases |
421 | 262 | |||||||||
Term loan payable |
3,928 | 2,321 | |||||||||
Notes payable |
22 | ||||||||||
Convertible subordinated debentures |
8,387 | 8,472 | |||||||||
Shareholders equity: |
|||||||||||
Series A Convertible Preferred Stock, par
$.01 - Authorized,
issued and outstanding, 3,125 shares |
24,946 | 24,946 | |||||||||
Common Stock, par $.01 - Authorized, 100,000 shares;
issued and outstanding, 42,187 and 51,464 shares |
173,318 | 199,904 | |||||||||
Accumulated other comprehensive loss |
(762 | ) | (347 | ) | |||||||
Accumulated deficit |
(157,752 | ) | (153,677 | ) | |||||||
| 39,750 | 70,826 | ||||||||||
TOTAL |
$ | 127,087 | $ | 140,697 | |||||||
See accompanying notes
3
CRAY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||
| 2001 | 2002 | 2001 | 2002 | |||||||||||||||||
REVENUE: |
||||||||||||||||||||
Product |
$ | 9,124 | $ | 21,322 | $ | 45,333 | $ | 55,491 | ||||||||||||
Service |
20,252 | 20,729 | 62,213 | 60,397 | ||||||||||||||||
Total revenue |
29,376 | 42,051 | 107,546 | 115,888 | ||||||||||||||||
OPERATING EXPENSES: |
||||||||||||||||||||
Cost of product revenue |
5,996 | 12,367 | 24,777 | 29,242 | ||||||||||||||||
Cost of service revenue |
11,116 | 12,063 | 29,780 | 32,755 | ||||||||||||||||
Research and development |
13,211 | 7,301 | 40,398 | 26,440 | ||||||||||||||||
Marketing and sales |
5,276 | 5,158 | 14,859 | 14,935 | ||||||||||||||||
General and administrative |
1,937 | 2,108 | 6,320 | 6,041 | ||||||||||||||||
Restructuring charge |
1,284 | 1,284 | 1,878 | |||||||||||||||||
Amortization of goodwill |
1,772 | 5,318 | ||||||||||||||||||
Total operating expenses |
40,592 | 38,997 | 122,736 | 111,291 | ||||||||||||||||
Income (loss) from operations |
(11,216 | ) | 3,054 | (15,190 | ) | 4,597 | ||||||||||||||
OTHER INCOME (EXPENSE), NET |
1,105 | 62 | (255 | ) | 2,464 | |||||||||||||||
INTEREST INCOME (EXPENSE), NET |
(209 | ) | (503 | ) | (1,490 | ) | (1,537 | ) | ||||||||||||
Income (loss) before income taxes |
(10,320 | ) | 2,613 | (16,935 | ) | 5,524 | ||||||||||||||
PROVISION FOR INCOME TAXES |
479 | 474 | 961 | 1,449 | ||||||||||||||||
Net income (loss) |
$ | (10,799 | ) | $ | 2,139 | $ | (17,896 | ) | $ | 4,075 | ||||||||||
Net income (loss) per common share: |
||||||||||||||||||||
Basic |
$ | (0.26 | ) | $ | 0.04 | $ | (0.45 | ) | $ | 0.09 | ||||||||||
Diluted |
$ | (0.26 | ) | $ | 0.04 | $ | (0.45 | ) | $ | 0.08 | ||||||||||
Weighted average shares outstanding: |
||||||||||||||||||||
Basic |
41,529 | 49,221 | 40,130 | 46,221 | ||||||||||||||||
Diluted |
41,529 | 59,923 | 40,130 | 51,291 | ||||||||||||||||
See accompanying notes
4
CRAY INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
(in thousands)
(unaudited)
| Series A | ||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | |||||||||||||||||||||||||||||
| Currency | ||||||||||||||||||||||||||||||
| Number of | Number of | Accumulated | Translation | |||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Deficit | Adjustment | Total | ||||||||||||||||||||||||
BALANCE, January 1, 2002 |
3,125 | $ | 24,946 | 42,187 | $ | 173,318 | $ | (157,752 | ) | $ | (762 | ) | $ | 39,750 | ||||||||||||||||
Common stock issued, less issuance costs
of $273 |
1,950 | 3,627 | 3,627 | |||||||||||||||||||||||||||
Exercise of warrants, less issuance costs
of $116 |
970 | 1,823 | 1,823 | |||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||
Cumulative currency translation adjustment |
(502 | ) | (502 | ) | ||||||||||||||||||||||||||
Net income |
749 | 749 | ||||||||||||||||||||||||||||
BALANCE, March 31, 2002 |
3,125 | $ | 24,946 | 45,107 | $ | 178,768 | $ | (157,003 | ) | $ | (1,264 | ) | $ | 45,447 | ||||||||||||||||
Issuance of shares under Employee
Stock Purchase Plan |
222 | 679 | 679 | |||||||||||||||||||||||||||
Issuance of shares under Company 401(k) Plan |
257 | 568 | 568 | |||||||||||||||||||||||||||
Common stock issued for accrued interest
notes payable |
96 | 224 | 224 | |||||||||||||||||||||||||||
Exercise of stock options |
260 | 677 | 677 | |||||||||||||||||||||||||||
Exercise of warrants, less issuance costs
of $429 |
2,390 | 8,940 | 8,940 | |||||||||||||||||||||||||||
Warrants issued for consulting services |
230 | 230 | ||||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||
Cumulative currency translation adjustment |
794 | 794 | ||||||||||||||||||||||||||||
Net income |
1,187 | 1,187 | ||||||||||||||||||||||||||||
BALANCE, June 30, 2002 |
3,125 | $ | 24,946 | 48,332 | $ | 190,086 | $ | (155,816 | ) | $ | (470 | ) | $ | 58,746 | ||||||||||||||||
Issuance of shares under Employee
Stock Purchase Plan |
89 | 299 | 299 | |||||||||||||||||||||||||||
Exercise of stock options |
102 | 219 | 219 | |||||||||||||||||||||||||||
Common stock issued, less issuance costs
of $700 |
2,941 | 9,300 | 9,300 | |||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||